Advertisement

Organisation › Details
Freenome (Group)
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. *
![]() |
Start | 2014-01-01 established |
Today | Freenome Inc. | |
![]() |
Industry | blood test |
Industry 2 | cancer test, early detection | |
![]() |
Region | South San Francisco, CA |
Country | United States (USA) | |
Street | 279 East Grand Avenue 5th Floor | |
City | 94080 South San Francisco, CA | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Freenome, Inc.. (5/22/23). "Press Release: Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd". South San Francisco, CA. | ||
Record changed: 2023-07-10 |
Advertisement

More documents for Freenome (Group)
- [1] Freenome, Inc.. (2/15/24). "Press Release: Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection". South San Francisco, CA....
- [2] Freenome, Inc.. (5/22/23). "Press Release: Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd". South San Francisco, CA....
- [3] Freenome, Inc.. (12/7/21). "Press Release: Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection". South San Francisco, CA....
- [4] Freenome, Inc.. (12/1/21). "Press Release: Freenome Partners with Siemens Healthineers for Breast Cancer Research". South San Francisco, CA....
- [5] Biognosys AG. (11/9/21). "Press Release: Biognosys Launches Next-Generation Blood Biomarker Discovery Solution". Schlieren....
- [6] Freenome, Inc.. (8/26/20). "Press Release: Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA....
- [7] Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services"....
- [8] ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA....
- [9] Freenome, Inc.. (7/24/19). "Press Release: Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA....
- [10] Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top